U-Blot® Research Grade EnsituximabCat. No. WA2800$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade EnsituximabCat. No. WA2800
U-Blot® Research Grade ensavatatugCat. No. WA2799
U-Blot® Research Grade EnristomigCat. No. WA2798
U-Blot® Research Grade EnoticumabCat. No. WA2797
U-Blot® Research Grade EnokizumabCat. No. WA2796
U-Blot® Research Grade EnoblituzumabCat. No. WA2795
U-Blot® Research Grade EnlonstobartCat. No. WA2794
U-Blot® Research Grade EnlimomabCat. No. WA2793
U-Blot® Research Grade EnibarcimabCat. No. WA2792
U-Blot® Research Grade EnfortumabCat. No. WA2791
U-Blot® Research Grade EncelimabCat. No. WA2790
U-Blot® Research Grade EnavatuzumabCat. No. WA2789